» Authors » F Kate Gould

F Kate Gould

Explore the profile of F Kate Gould including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 891
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Evans R, Pike K, Rogers C, Reynolds R, Stoddart M, Howe R, et al.
BMC Infect Dis . 2020 Jul; 20(1):545. PMID: 32711452
Background: Bloodstream infection is common in the UK and has significant mortality depending on the pathogen involved, site of infection and other patient factors. Healthcare staffing and ward activity may...
2.
Brown E, Gould F
J Antimicrob Chemother . 2020 Apr; 75(8):2021-2027. PMID: 32240296
Current guidelines for management of infective endocarditis (IE) advise 4-6 weeks of IV antibiotics. This is based on historical data from animal models, which set a precedent for high peak...
3.
Nair A, Perry A, Perry J, Gould F, Samuel J
J Antimicrob Chemother . 2019 Dec; 75(3):586-592. PMID: 31846037
Objectives: Pseudomonas aeruginosa is an important pathogen in chronic suppurative respiratory diseases, with adverse effects on severity, healthcare utilization and quality of life. Aerosolized combined biofilm disruption and iron chelators...
4.
Birch J, Sunny S, Hester K, Parry G, Gould F, Dark J, et al.
BMC Pulm Med . 2018 May; 18(1):82. PMID: 29789006
Background: Lung transplantation is a well-established treatment for end-stage non-cystic fibrosis bronchiectasis (BR), though information regarding outcomes of transplantation remains limited. Our results of lung transplantation for Br are reported...
5.
Liew Z, Mallikarjuna S, Hasan A, Gould F, Bunn S, Thomas M, et al.
BMC Pulm Med . 2017 Jan; 17(1):17. PMID: 28086849
Background: Cystic fibrosis lung disease is generally a diffuse process however rarely one lung may become particularly damaged through chronic collapse and consolidation resulting in end-stage bronchiectasis with relative sparing...
6.
Gould F, Lewis R, Richardson M
J Antimicrob Chemother . 2016 Nov; 71(suppl 2):ii1. PMID: 27880662
No abstract available.
7.
Gould F, Denning D, Elliott T, Foweraker J, Perry J, Prendergast B, et al.
J Antimicrob Chemother . 2011 Nov; 67(2):269-89. PMID: 22086858
The BSAC guidelines on treatment of infectious endocarditis (IE) were last published in 2004. The guidelines presented here have been updated and extended to reflect developments in diagnostics, new trial...
8.
Nicholson A, Perry J, James A, Stanforth S, Carnell S, Wilkinson K, et al.
Int J Antimicrob Agents . 2011 Oct; 39(1):27-32. PMID: 21993484
The aim of this study was to establish the antimicrobial activities of S-(3,4-dichlorobenzyl)isothiourea hydrochloride (A22) and a series of structurally related compounds against multidrug-resistant (MDR) bacteria. The minimum inhibitory concentrations...
9.
Gould F
J Antimicrob Chemother . 2011 Apr; 66 Suppl 4:iv3-iv6. PMID: 21521705
Linezolid has been in general use in the UK since 2000. Although toxicity, particularly haematological and neurological, has been an issue, linezolid has proved to be an effective alternative to...
10.
Soyza A, Meachery G, Hester K, Nicholson A, Parry G, Tocewicz K, et al.
J Heart Lung Transplant . 2010 Sep; 29(12):1395-404. PMID: 20810293
Background: Pre-operative infection with organisms from the Burkholderia cepacia complex (BCC), particularly B cenocepacia, has been linked with a poorer prognosis after transplantation compared to patients with cystic fibrosis (CF)...